CHOLERA- A CHALLENGE TO CURTAIL IN DEVELOPING COUNTRY
DOI:
https://doi.org/10.69723/njms.03.04.0413Abstract
OBJECTIVE : To determine the bacterial causative agent and associated risk factors responsible for sudden increase in cases of acute diarrheal disease in Rawalpindi/Islamabad Pakistan and to find the antimicrobial susceptibility pattern of isolates.
METHODOLOGY: A Cross-sectional observational study was carried out at Department of Microbiology, Army Medical College (National University of Medical Sciences) from 18th May 2022 to 30th July 2022. Case definition was defined and all stool specimens were processed according to Clinical Microbiology procedures hand book edition four. Bacterial growth was identified by biochemical reactions and was further confirmed by serology. Antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion method following Clinical and Laboratory Standards Institute M45-A-2 document.
Risk factors like age, gender, socio economic determinants, provision of safe drinking water, availability of toilets and hygiene facilities. History was evaluated through structured questionnaire after obtaining informed consent. Data was analyzed using statistical package for social sciences version 26 and correlation was determined between different risk factors and presence of disease.
RESULTS : A total of 51 patients were recruited in the study. The mean age of positive cases was 40.80 years. All isolates were identified as biotype Classical serotype Ogawa and had same antibiotic susceptibility pattern i.e. Ampicillin, Azithromycin, Chloramphenicol, Tetracycline, Doxycyline, Ciprofloxacin sensitive to except trimethoprim-sulfamethoxazole.
CONCLUSION : The organism responsible for rise in cases of acute diarrhea was Vibrio Cholera. A rise in cholera cases was associated with significant hospitalizations and mortality. With the increase rising trend of cholera cases in our hospital and Pakistan, we determined antibiotic susceptibility patterns of the Vibrio Cholerae. To overcome this threat, provision of safe drinking water, testing facilities and proper sewage should be available.
KEYWORDS : Cholera, Developing countries Outbreak, Risk factors
References
Larkin H. WHO Report: Cholera Resurgent in 2022 After Years of Decline. JAMA. 2023;329(3):200. DOI: 10.1001/jama.2022.23551
Islam MT, Ross AG, Sleigh AC, Chowdhury F, Khan AI, McMillan NA, et al. A blueprint for eliminating cholera by 2030. Nat Med. 2022;28(9):1747–9. DOI: 10.1038/s41591-022-01898-w.
Malikzai A, Qamar K, Malik UU, Rafique F, Shaeen SK. Cholera spike following monsoon floods in Pakistan: Challenges, efforts and recommendations. Int J Surg Open. 2023;57:100652. • DOI: 10.1016/j.ijso.2023.100652.
Paye NG, Miller RHB, Zhou C, Weamie SJY, Davies TA. Systematic study and meta-analysis of risk factors associated with cholera outbreaks in africa: a review. Adv Infect Dis. 2021;11(2):240–60. DOI: 10.4236/aid.2021.112022.
Muzembo BA, Kitahara K, Debnath A, Ohno A, Okamoto K, Miyoshi S-I. Cholera outbreaks in India, 2011–2020: A systematic review. Int J Environ Res Public Health. 2022;19(9):5738. DOI: 10.3390/ijerph19095738.
Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine. 2020;38:A31–40. DOI: 10.1016/j.vaccine.2019.07.078.
Khan HA, Masood W, Siddiqui A, Ahmad S, Salman Y, Essar MY. The Cholera outbreak in Karachi, Pakistan: challenges, efforts and recommendations. Ann Med Surg. 2022;78:103873. DOI: 10.1016/j.amsu.2022.103873
Naveed A, Umer M, Ehsan M, Ayyan M, Shahid A, Zahid A, et al. The cholera outbreak in Lahore, Pakistan: challenges, efforts and recommendations. Trop Med Health. 2022;50(1):1–3. DOI: 10.1186/s41182-022-00458-9
Akram KS, Malik MW, Khan MA, Tahir MA, Adeel SS, Baig AM. Epidemiological Investigations of Acute Watery Diarrhea Outbreak During July-August 2017 in Amarpura, Rawalpindi - Pakistan. Pakistan J Public Heal. 2019;9(2):74–7. DOI: 10.32413/pjph.v9i2.204
Umair M, Khan M, Jabbar A, Khan SA, Hamayun M, Khan TA. Post-flood outbreaks of Cholera in Pakistan; Endemic-to-epidemic. J Infect Dev Ctries. 2023;17(03):423–4. DOI: 10.3855/jidc.17512
Pal BB, Khuntia HK, Nayak SR, Mohanty A, Biswal B. Vibrio cholerae O1 Ogawa strains carrying the ctxB7 allele caused a large cholera outbreak during 2014 in the tribal areas of Odisha, India. Jpn J Infect Dis. 2017;70(5):549–53. DOI: 10.7883/yoken.JJID.2016.585
Gwenzi W, Sanganyado E. Recurrent cholera outbreaks in sub-Saharan Africa: moving beyond epidemiology to understand the environmental reservoirs and drivers. challenges. 2019;10(1):1. https://doi.org/10.3390/challe10010001
Zerbo A, Delgado RC, González PA. A review of the risk of cholera outbreaks and urbanization in sub-Saharan Africa. J Biosaf Biosecurity. 2020;2(2):71–6. DOI:10.1016/j.jobb.2020.11.004
Elimian KO, Musah A, Mezue S, Oyebanji O, Yennan S, Jinadu A, et al. Descriptive epidemiology of cholera outbreak in Nigeria, January–November, 2018: implications for the global roadmap strategy. BMC Public Health. 2019;19(1):1–11. doi: 10.1186/s12889-019-7559-6.
Dinede G, Abagero A, Tolosa T. Cholera outbreak in Addis Ababa, Ethiopia: a case-control study. PLoS One. 2020;15(7):e0235440. DOI: 10.1371/journal.pone.0235440
Ocasio DV, Juin S, Berendes D, Heitzinger K, Prentice-Mott G, Desormeaux AM, et al. Cholera outbreak—Haiti, September 2022–January 2023. Morb Mortal Wkly Rep. 2023;72(2):21. DOI: 10.15585/mmwr.mm7202a1
Dureab F, Jahn A, Krisam J, Dureab A, Zain O, Al-Awlaqi S, et al. Risk factors associated with the recent cholera outbreak in Yemen: a case-control study. Epidemiol Health. 2019;41. DOI: 10.4178/epih.e2019015
Saha A, Rosewell A, Hayen A, MacIntyre CR, Qadri F. 2017. Improving immunization approaches to cholera. Expert Rev Vaccines 16:235–248. DOI: 10.1080/14760584.2017.1249470
Ilic I, Ilic M. Global patterns of trends in cholera mortality. Trop. med. infect.
Mar 13;8(3):169. DOI: 10.3390/tropicalmed8030169
Jubyda FT, Nahar KS, Barman I, Johura FT, Islam MT, Sultana M, Ullah W, Tasnim J, Biswas SR, Monir MM, George CM. Vibrio cholerae O1 associated with recent endemic cholera shows temporal changes in serotype, genotype, and drug-resistance patterns in Bangladesh. Gut Pathog.. 2023 Apr 12;15(1):17. DOI: 10.1186/s13099-023-00537-0
Junejo S, Shahid S, Khursheed N, Maqsood S, Adnan F, Khalid F. Cholera outbreak in 2022 among children in Karachi: Study of cases attending to a Tertiary Care Hospital. PaK J Med Sci. 2023 Sep;39(5):1496. DOI: https://doi.org/10.12669/pjms.39.5.7395
Gupta PK, Pant ND, Bhandari R, Shrestha P. Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrob. Resist. Infect. Control. 2016 Dec;5:1-5. DOI 10.1186/s13756-016-0122-7.
Luby SP, Davis J, Brown RR, Gorelick SM, Wong TH. Broad approaches to cholera control in Asia: Water, sanitation and handwashing. Vaccine. 2020 Feb 29;38:A110-7. DOI: 10.1016/j.vaccine.2019.07.084.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Afnan Naeem, Faisal hanif, Javaid usman, Amber qasim, Warda Furqan, Azka zulfiqar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
